Results 31 to 40 of about 1,034,274 (259)

Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies

Annals of the Rheumatic Diseases, 2023
Objectives Bimekizumab (BKZ), a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A, has demonstrated superior efficacy versus placebo in patients with non-radiographic (nr-) and radiographic (r-) axial ...
X. Baraliakos, A. Deodhar, D. M. van der Heijde, M. Magrey, W. Maksymowych, Tetsuya Tomita, Huji Xu, U. Massow, C. Fleurinck, Alicia M Ellis, T. Vaux, J. Shepherd-Smith, Alexander Marten, L. Gensler   +13 more
semanticscholar   +1 more source

Effects of COVID-19 on axial spondyloarthritis disease flare

, 2022
Aims:Rheumatological disease flares may occur after many infections. However, our knowledge of the post-Coronavirus disease-2019 (COVID-19) axial spondyloarthritis (SpA) flares and related factors is limited.Methods:We retrospectively assessed the axial ...
ERDEN, ABDULSAMET, Bahar Özdemir, ATALAR, EBRU, GÜVEN, SERDAR CAN, Ebru Atalar, ÖZDEMİR, BAHAR, Esra Kayacan Erdoğan, Serdar Can Güven, İsmail Doğan, Abdulsamet Erden, KARAKAŞ, ÖZLEM, Özlem Karakaş, Berkan Armağan, KÜÇÜKŞAHİN, ORHAN, ARMAĞAN, BERKAN, KAYACAN ERDOĞAN, ESRA, DOĞAN, İSMAİL, Orhan Küçükşahin, Erdoğan, Esra Kayacan   +18 more
core   +1 more source

Spondyloarthritis Research and Treatment Network Recommendations for the Referral of Adults With Chronic Back Pain and Suspected Axial Spondyloarthritis to a Rheumatologist. [PDF]

ACR Open Rheumatol
Objective In the United States, axial spondyloarthritis (axSpA) diagnosis is delayed up to 14 years preventing effective management. We convened a multidisciplinary clinician and patient group to develop recommendations for rheumatology referral of adults with chronic back pain.
Dubreuil M, Danve A, Liew JW, Alexander SA, Afinogenova Y, Bittar M, Fraenkel L, Grimshaw A, Kumthekar A, LaValley MP, Magrey MN, Majithia V, Merjanah S, Norton H, Walsh JA, Deodhar A.   +15 more
europepmc   +2 more sources

Cardiovascular risk in axial spondyloarthritis—a systematic review

Clinical Rheumatology, 2023
Cardiovascular manifestations are common in patients suffering axial spondyloarthritis and can result in substantial morbidity and disease burden.
Rainer Hintenberger, Barbara Affenzeller, Valeriia Vladychuk, H. Pieringer   +3 more
semanticscholar   +1 more source

Progression of axial spondyloarthritis

Современная ревматология, 2021
The spectrum of bone lesions in axial spondyloarthritis is of great interest. With inflammation and mechanical influence concurrence in the background, both tissue gain and tissue loss in a particular bone area can occur simultaneously.
Sh. F. Erdes, T. V. Korotaeva
doaj   +1 more source

Prevalence of pistol-grip deformity in patients with axial spondyloarthritis

, 2021
OBJECTIVE: To our knowledge, the prevalence of pistol-grip deformity (PGD) has not previously been studied in patients with axial spondyloarthritis (axSpA). This study aimed to evaluate PGD prevalence in patients with axSpA and to assess its relationship
Gokay Karaca, Fatih Esad Topal, Dilek Solmaz, Tosun, Aliye, Aliye Tosun, Ozgur Tosun, Mustafa Ozmen, Topal, Fatih Esad, Tosun, Özgür, Karaca, Gökay, Özmen, Mustafa, Akar, Servet, Servet Akar, Solmaz, Dilek   +13 more
core   +1 more source

Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases

Reumatismo, 2021
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can show musculoskeletal symptoms such as peripheral arthritis. In rare cases, peripheral arthritis can develop after the resolution of SARS-CoV-2.
G. El Hasbani, A. Jawad, I. Uthman
doaj   +1 more source

The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis.

Annals of the Rheumatic Diseases
OBJECTIVES To develop a consensus-based expert definition of difficult-to-manage (D2M) axial spondyloarthritis (axSpA), incorporating treatment-refractory (TR) disease. METHODS A literature review was conducted in 2022 to identify potential definitions
D. Poddubnyy, V. Navarro-Compán, Murat Torgutalp, S. Arends, S. Aydin, S. Battista, F. E. Van den Bosch, C. Bundy, A. Cauli, J. Davies, M. Dougados, T. Duruöz, Bassel Elzorkany, W. Fong, F. V. van Gaalen, R. García-Salinas, Marco Garrido Cumbrera, P. Géher, L. Gensler, Simeon Grazio, Feng Huang, M. Kishimoto, R. Landewé, Ying-Ying Leung, P. M. Machado, H. Marzo-Ortega, Bhowmik Meghnathi, A. Moltó, E. Nikiphorou, S. Ramiro, M. Rudwaleit, C. Saad, A. Sepriano, James Wei, X. Baraliakos, D. M. van der Heijde   +35 more
semanticscholar   +1 more source

Difficult-to-treat axial spondyloarthritis is associated with psoriasis, peripheral involvement and comorbidities: results of an observational nationwide study

RMD Open, 2023
Objectives To determine the cumulative incidence and identify the factors associated with difficult-to-treat axial spondyloarthritis (D2T-axSpA) in French patients newly benefiting from the French ‘long-term illness’ (LTI) social security scheme for ...
Olivier Fakih, M. Desmarets, Bérenger Martin, C. Prati, Elisabeth Monnet, F. Verhoeven, D. Wendling   +6 more
semanticscholar   +1 more source

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis

, 2021
Background: The understanding of non-radiographic axial spondyloarthritis (nr-axSpA) has accelerated over the last decade, producing a number of practice-changing developments. Diagnosis is challenging.
Schachna, L, Saad, NF, Robinson, PC, Taylor, AL, Truong, SL, McEwan, T, Bird, P, Lim, I   +7 more
core   +1 more source